Artelo Biosciences Inc (ARTL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2022 | 03-2022 | 12-2021 | 11-2021 | 09-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -4,414 | -1,965 | N/A | -2,548 | -6,192 |
| Accounts payable and accrued liabilities | 29 | 23 | N/A | N/A | 5 |
| Other Working Capital | -866 | -739 | N/A | 47 | -322 |
| Other Operating Activity | 1,232 | 628 | 0 | 575 | 1,654 |
| Operating Cash Flow | $-4,019 | $-2,053 | $N/A | $-1,926 | $-4,855 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -3,186 | -2,446 | N/A | -10,758 | -5,029 |
| Sale Of Investment | 7,428 | 2,703 | N/A | 1,880 | 3,100 |
| Investing Cash Flow | $4,242 | $257 | $N/A | $-8,878 | $-1,929 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | N/A | N/A | N/A | 18,262 | 7,617 |
| Other Financing Activity | -134 | 0 | 0 | 0 | -7 |
| Financing Cash Flow | $-134 | $N/A | $N/A | $18,262 | $7,610 |
| Exchange Rate Effect | -129 | -16 | N/A | -40 | -23 |
| Beginning Cash Position | 12,162 | 12,162 | N/A | 6,629 | 5,783 |
| End Cash Position | 12,122 | 10,350 | N/A | 14,047 | 6,586 |
| Net Cash Flow | $-40 | $-1,812 | $N/A | $7,418 | $803 |
| Free Cash Flow | |||||
| Operating Cash Flow | -4,019 | -2,053 | N/A | -1,926 | -4,855 |
| Free Cash Flow | -4,019 | -2,053 | 0 | -1,926 | -4,855 |